StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
DMRADamora Therapeutics, Inc.
stockpulse.co.kr
Nasdaq
$21.12▼ 0.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.30BShares out 61.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

16
  • 9.28Pre-market26.09.28 20:00
    4Ownership#●●●

    Damora Therapeutics, Inc.

    Insider Jennifer Jarrett of Damora Therapeutics, Inc. reported a change in beneficial ownership of securities as of September 25, 2026. This filing is a standard Form 4 disclosure regarding insider holdings.…more

    $21.12-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 8.13Pre-market26.08.13 13:15filed
    EFFECTOther

    Damora Therapeutics, Inc.

    Damora Therapeutics' registration statement was declared effective by the SEC on August 12, 2026. This effectiveness allows the company to officially proceed with the issuance and sale of securities as outlined in the filing.…more

    $21.12-0.09%vs prev close
    View filingShare
  • 8.10After-hours26.08.11 06:28
    S-8 POSOffering

    Damora Therapeutics, Inc.

    Damora Therapeutics는 2026년 7월 16일부로 법인 소재지를 델라웨어주에서 케이맨 제도로 이전하는 'Redomestication'을 완료했습니다. 이에 따라 기존 델라웨어 법인의 보통주 및 우선주, 스톡옵션, 제한조건부주식(RSU), 워런트가 케이맨 제도 법인의 주식 및 권리로 1대 1 비율로 전환되었습니다.…more

    $21.12-0.09%vs prev close
    View filingShare

15 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.2Pre-market26.10.02 20:59
    #●●●#●●●

    Damora Therapeutics Grants Inducement Stock Options to New Hires

    Damora Therapeutics has granted stock options for 144,400 shares to five newly hired non-executive employees. This is a standard compensation practice for talent acquisition and does not impact the company's immediate financial performance.…more

    $21.12-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 8.3After-hours26.08.04 05:01

    ●●●●●●●● ●●●●● ●●●●●●

    다모라 테라퓨틱스가 신규 채용된 비임원급 직원 6명을 대상으로 총 45만 1천 주 규모의 주식매수선택권을 부여했습니다. 이는 우수 인재 영입을 위한 통상적인 보상 절차로, 주가에 미치는 직접적인 영향은 제한적입니다.…more

    $21.12-0.09%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →